Ticker LaunchRegulation A · Tier 2
Algernon Neuroscience Inc.
Algernon Neuroscience Inc. filed a Tier 2 Regulation A offering statement (Form 1-A) on Dec 30, 2022 for up to $10M at $1.00 per security. The SEC qualified the offering on Mar 8, 2023.
- Status
- Qualified
- Tier
- Tier 2
- Offering size
- $10M
- Offer price
- $1.00
- Security type
- Equity (common or preferred stock)
- Filed
- Dec 30, 2022
- Qualified
- Mar 8, 2023
- Industry
- Pharmaceutical Preparations
- State
- British Columbia, Canada
More on this offering for subscribers
- Revenue, net income and total assets from the offering statement
- Employees
- Market cap at the offer price
- Auditor
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
Other qualified Biotech & pharma Reg A offerings
- Starpax Biopharma Inc.Sep 11, 2023 · $24M
- CancerVAX, Inc.May 30, 2023 · $10M
- Sibannac, Inc.Mar 15, 2023 · $6M
- Shackelford Pharma Inc.Dec 12, 2022 · $12M
- MXY Holdings Inc.Oct 21, 2022 · $75M
- Maverick Lifestyle Inc.Sep 6, 2022 · $25M